Literature DB >> 8453040

On the origin of Alzheimer's disease: a hypothesis.

G W Roberts1, M Nash, P G Ince, M C Royston, S M Gentleman.   

Abstract

There is no unifying hypothesis to account for the anatomical distribution of neuropathology, the involvement of beta-amyloid precursor protein (beta APP) and the role of increasing age in triggering the Alzheimer disease process. We report here that layer II pre-alpha neurones in transentorhinal and entorhinal cortex contain more beta APP immunoreactivity than other cortical neurones in normal individuals. This immunoreactivity increased in the early stages of Alzheimer's disease and was lost as the disease progressed. These neurones are known to undergo genetically programmed re-sprouting and synaptogenesis during the fifth and sixth decades of life. We hypothesize that these phenomena are related and that the Alzheimer's disease process originates in entorhinal cortex neurones due to the enhancement of their normally high content of beta APP during age-related resprouting.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453040     DOI: 10.1097/00001756-199301000-00001

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

2.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease.

Authors:  G W Roberts; S M Gentleman; A Lynch; L Murray; M Landon; D I Graham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

3.  Heterogeneity of Alzheimer's disease. An interpretive review.

Authors:  H H Fudenberg
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

4.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus.

Authors:  E Masliah; W G Honer; M Mallory; M Voigt; P Kushner; L Hansen; R Terry
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity.

Authors:  J G Sheng; F A Boop; R E Mrak; W S Griffin
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

7.  Cortical and striatal neurone number in Huntington's disease.

Authors:  H Heinsen; M Strik; M Bauer; K Luther; G Ulmar; D Gangnus; G Jungkunz; W Eisenmenger; M Götz
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Selective vulnerability in neurodegenerative diseases.

Authors:  Hongjun Fu; John Hardy; Karen E Duff
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

9.  Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.

Authors:  Rachael I Scahill; Gerard R Ridgway; Jonathan W Bartlett; Josephine Barnes; Natalie S Ryan; Simon Mead; Jonathan Beck; Matthew J Clarkson; Sebastian J Crutch; Jonathan M Schott; Sebastien Ourselin; Jason D Warren; John Hardy; Martin N Rossor; Nick C Fox
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions.

Authors:  A A Grolla; J A Sim; D Lim; J J Rodriguez; A A Genazzani; A Verkhratsky
Journal:  Cell Death Dis       Date:  2013-05-09       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.